INDP NASDAQ
Indaptus Therapeutics, Inc.
1W: +11.8%
1M: +0.6%
3M: +81.9%
YTD: +20.8%
1Y: -8.8%
3Y: -95.4%
5Y: -98.5%
$3.31
-0.04 (-1.05%)
Weekly Expected Move ±25.1%
$2
$2
$3
$4
$5
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -6.32.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ETF Exposure
5
ETFs Holding
Total ETF Value
0.00%
Max Weight
0.001%
Avg Weight
ETF Holdings by Value
ETFs Holding INDP
| # | ETF | Weight | Value | Holdings | Top 10 Wt | P/E | Div Yield | Sector Mix |
|---|---|---|---|---|---|---|---|---|
| 1 |
VXF
Vanguard Extended Market ETF
|
0.0003% | 3,322 | 9.5% | 3.8 | 0.01% | ||
| 2 | VEMPX | 0.0003% | 3,322 | 9.5% | 3.8 | 0.01% | ||
| 3 | VIEIX | 0.0003% | 3,322 | 9.5% | 3.8 | 0.01% | ||
| 4 | VEXAX | 0.0003% | 3,322 | 9.5% | 3.8 | 0.01% | ||
| 5 | FNCMX | —% | 2,781 | 57.5% | 72.7 | 0.27% | ||
| 6 |
MSSM
Morgan Stanley Pathway Funds - Small-Mid Cap Equity ETF
|
0.0048% | 1,818 | 6.1% | 16.1 | 0.01% | ||
| 7 | FSMAX | —% | 3,181 | 8.8% | 12.6 | 0.01% | ||
| 8 | FSKAX | —% | 3,600 | 34.8% | 51.6 | 0.01% |
Tech
Financial
Healthcare
Consumer Cycl.
Industrials
Energy